Page last updated: 2024-11-02

oxymetazoline and Erythromelalgia

oxymetazoline has been researched along with Erythromelalgia in 1 studies

Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.

Erythromelalgia: A peripheral arterial disease that is characterized by the triad of ERYTHEMA, burning PAIN, and increased SKIN TEMPERATURE of the extremities (or red, painful extremities). Erythromelalgia may be classified as primary or idiopathic, familial or non-familial. Secondary erythromelalgia is associated with other diseases, the most common being MYELOPROLIFERATIVE DISORDERS.

Research Excerpts

ExcerptRelevanceReference
"Erythromelalgia is an infrequent syndrome with a profound impact on quality of life."5.72Successful treatment of knee erythromelalgia with topical oxymetazoline. ( Altemir, A; Barrabés-Torrella, C; Iglesias-Sancho, M; Salleras-Redonnet, M; Sanchez-Regaña, M, 2022)
"Erythromelalgia is an infrequent syndrome with a profound impact on quality of life."1.72Successful treatment of knee erythromelalgia with topical oxymetazoline. ( Altemir, A; Barrabés-Torrella, C; Iglesias-Sancho, M; Salleras-Redonnet, M; Sanchez-Regaña, M, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Altemir, A1
Iglesias-Sancho, M1
Barrabés-Torrella, C1
Sanchez-Regaña, M1
Salleras-Redonnet, M1

Other Studies

1 other study available for oxymetazoline and Erythromelalgia

ArticleYear
Successful treatment of knee erythromelalgia with topical oxymetazoline.
    Clinical and experimental dermatology, 2022, Volume: 47, Issue:4

    Topics: Erythromelalgia; Humans; Oxymetazoline; Quality of Life

2022